Hyaluronidase (Human Recombinant) + Pertuzumab + Trastuzumab

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
PhesgoCA ES EU MX US
  • injection Hyaluronidase (Human Recombinant) 20,000 unit/10 mL + Pertuzumab 600 mg/10 mL + Trastuzumab 600 mg/10 mL
  • injection Hyaluronidase (Human Recombinant) 30,000 unit/15 mL + Pertuzumab 1,200 mg/15 mL + Trastuzumab 600 mg/15 mL
  • injection ×3 Pertuzumab 1,200 mg + Trastuzumab 600 mg
  • liquid ×2 Pertuzumab + Trastuzumab

Other 4 compositions

Roche Registration Gmbh
pertuzumab, trastuzumab, and hyaluronidase-zzxfUS1,200 mg/15 mL / 600 mg/15 mL / 30,000 unit/15 mL / 600 mg/10 mL / 20,000 unit/10 mLGenentech, Inc.

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.